This is a meta-analysis of previously published data. All the collected information are listed in the [Table 1](#pone.0165861.t001){ref-type="table"} of the present meta-analysis.

Introduction {#sec005}
============

Cognitive disorders are a category of mental disease that affects memory, language, learning and problem solving. Alzheimer's disease (AD) and cognitive impairment (CoI) are two common cognitive disorders in elderly and negatively affect the elders' life. Cognitive disorders are caused by a complex of genetics and environmental factors \[[@pone.0165861.ref001],[@pone.0165861.ref002]\]. Because of limited treatment of cognitive disorders, the prevention or onset delay of the disease through modification of risk factors such as lifestyles are proposed \[[@pone.0165861.ref003],[@pone.0165861.ref004]\]. Some lifestyles, such as folic acid supplementation \[[@pone.0165861.ref005]\], flavonoid-rich food \[[@pone.0165861.ref006]\] and caffeine contained drinks \[[@pone.0165861.ref007]\] have been reported to be inversely associated with the risk of cognitive disorders.

Tea, a flavonoid-rich and caffeine contained drink, is popular worldwide. Recent studies proposed that drinking tea may reduce the risk of AD and CoI \[[@pone.0165861.ref008]\]. Kuriyama et al. \[[@pone.0165861.ref009]\] stated that the higher green tea consumption was associated with the lower prevalence of CoI in humans. Ide et al. \[[@pone.0165861.ref010]\] also found that the green tea intake could improve the cognitive function or delay the progression of cognitive dysfunction in elders. However, some other researchers presented the opposite results showing no obvious association between tea drinking and cognitive disorders \[[@pone.0165861.ref011],[@pone.0165861.ref012]\].

Several systematic review or meta-analyses on this issue have been reported. However, these analyses only examined the effect of one major component in tea such as caffeine \[[@pone.0165861.ref013]\] or flavonoids \[[@pone.0165861.ref014]\], and some other caffeine contained food or drinks like coffee were also considered in these analyses.

In this study, we performed a new meta-analysis to specifically and systematically evaluate the association between tea drinking and the incidence of cognitive disorders such as AD and CoI by using pooled analysis of the published observational studies. Since China has the most tea drinkers in the world, the related Chinese reports were included in our meta-analysis.

Materials and Methods {#sec006}
=====================

Literature search {#sec007}
-----------------

We searched PubMed (<http://www.ncbi.nlm.nih.gov/pubmed/>), Embase (<https://www.embase.com/>) and Chinese Wanfang database (<http://www.wanfangdata.com.cn/>) up to September, 2015 using the search terms of "tea AND (Alzheimer disease OR dementia OR cognitive\*)" in English and Chinese. We also searched the references from the included studies and relevant reviews to identify additional publications. The study selection process was performed following the PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analyses) statement \[[@pone.0165861.ref015]\]. The PRISMA checklist for this meta-analysis was shown in [S1 File](#pone.0165861.s001){ref-type="supplementary-material"}.

Selection criteria {#sec008}
------------------

We selected the studies which conformed with the following criteria: 1) only observational studies with case-control, cohort and cross-sectional design were considered due to the lack of relevant double-blind placebo controlled trials; 2) the study reported the relationship between tea consumption and cognitive disorders such as AD, cognitive decline and CoI in elderly; 3) the study provided the data for calculating the estimates of odds ratio (OR) and the corresponding 95% confidence interval (CI).

The animal studies, reviews, reports and studies with unavailable data were excluded. If two or more studies shared the same population, we only selected the latest one. Two of us (Ma and Huang) completed the literature search process independently and the disagreements were resolved by discussion.

Data extraction and quality assessment {#sec009}
--------------------------------------

Huang and Cui independently extracted the main information of the included studies using the predesigned form and assessed the methodological quality of the case-control and cohort studies using the Newcastle-Ottawa Scale (NOS) \[[@pone.0165861.ref016]\]. The NOS contained 3 aspects with 8 items: selection of the participants (4 items), comparability of the cohorts/cases and controls (1 item) and the exposure/outcomes (3 items). The total score was 9 stars with 1 star for each item and 2 stars for the item of comparability. In this study, 7, 4--6 and \< 4 stars were considered as high, moderate and low quality, respectively. The discrepancies were discussed with the third reviewer (Yang).

Statistical analysis {#sec010}
--------------------

We pooled the odds ratio (OR) and the corresponding 95% confidence interval (CI) using fixed or random effects models according to the degree of heterogeneity. The heterogeneity was assessed by *I*^*2*^ statistic, which measures the extent of true heterogeneity dividing the difference between the result of the *Q* test and its degrees of freedom (*k*-- 1) by the *Q* value itself, and multiplied by 100 \[[@pone.0165861.ref017]\]. *I*^*2*^ \> 50% was considered as heterogeneity and the pooled analysis was conducted using a random effects model. Otherwise, the fixed effect model was used. We conducted the subgroup analysis according to study design, population, drink frequency and type of cognitive disorder. For drink frequency, the studies without description of the drink frequency were classified into "ungrouped subgroup". These analyses were conducted using Stata 13 software. In addition, publication bias was assessed using Begg's and Egger's test.

Results {#sec011}
=======

Study selection {#sec012}
---------------

The study selection process was shown in [Fig 1](#pone.0165861.g001){ref-type="fig"}. Our initial search resulted in retrieval of 1 528 articles (397 from PubMed, 1 027 from Embase and 104 from Wanfang). Firstly, we took out 1 090 duplicate records by preliminary screening. Secondly, 370 animal studies or reviews which obviously deviated from inclusion criteria were removed by reading titles and abstracts. Thirdly, we removed 42 articles after reviewing the full-texts and the reasons for exclusion were listed in [S2 File](#pone.0165861.s002){ref-type="supplementary-material"}. Finally, 26 studies were included in this meta-analysis \[[@pone.0165861.ref006],[@pone.0165861.ref009],[@pone.0165861.ref011],[@pone.0165861.ref012],[@pone.0165861.ref018]--[@pone.0165861.ref039]\].

![Study selection process for this meta-analysis.](pone.0165861.g001){#pone.0165861.g001}

Study characteristics {#sec013}
---------------------

[Table 1](#pone.0165861.t001){ref-type="table"} summarized the characteristics of the 26 selected studies including 10 case-control studies, 4 cohorts and 12 cross-sectional studies. These studies contained 52 503 participants distributed in Asia, Europe, Australia and America. All of the participants were 50 years and older. For diagnosis of the study outcomes, Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) was used for dementia diagnosis, National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer\'s Disease and Related Disorders Association (NINCDS-ADRDA) for AD diagnosis and Mini-Mental State Examination (MMSE) for CoI diagnosis. Cognitive impairment contains all the patients falling in between healthy and demented states in these included studies. Mild cognitive impairment (MCI) was defined as an early state of cognitive impairment in the included studies. In addition, cognitive decline was defined as a drop of ≥1--2 MMSE scores from the baseline. Some other auxiliary criteria such as Montreal Cognitive Assessment (MoCA), Mini-Cog and Petersen's criteria were also used in combination for diagnosis of these cognitive disorders ([Table 1](#pone.0165861.t001){ref-type="table"}).

10.1371/journal.pone.0165861.t001

###### Characteristics of the included studies in this meta-analysis.

![](pone.0165861.t001){#pone.0165861.t001g}

  Study                                               Population                                            Study design                            n (male/female)       mean consumption                                                                                                      Assessment of cognitive status                                                                                          Cognitive results                                                                                                                                                                                                                                                  Adjust factors
  --------------------------------------------------- ----------------------------------------------------- --------------------------------------- --------------------- --------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Broe 1990 \[[@pone.0165861.ref032]\]                Australian (52--96)                                   hospital based case-control             340 (170/170)         drinking vs. never; \>4cups/d vs. \< 4cups/d                                                                          Neurology of Aging Schedule, MMSE, comprehent neuropsychological assessment, NINCDS-ADRDA for probable or possible AD   drinking in cases 162, drinking in controls 166; \>4cups/d in cases: 73, in control 58; never drink in cases 8, in controls 4                                                                                                                                      Age, sex and, where possible, the general practice of origin.
  Chen 2012 \[[@pone.0165861.ref018]\]                Chinese (≥65)                                         prospective nested case-control study   5,691 (1,389/4,302)   tea drinking vs. not drinking                                                                                         MMSE-r less than 18 for cognitive decline                                                                               OR = 0.82 (0.68, 1.00)                                                                                                                                                                                                                                             NA
  Cheng 2014 \[[@pone.0165861.ref019]\]               Chinese (\>60)                                        cross-sectional                         3,885 (2,379/1,506)   tea drinking vs. not drinking                                                                                         DSM-IV, and clinical evaluation for dementia; HDS and CMS for CoI                                                       484 CI patients in 1927 non tea drinkers, 437 CI patients in 1958 tea drinkers                                                                                                                                                                                     NA
  Dai 2006 \[[@pone.0165861.ref035]\]                 Japanese Americans in King County, Washington (≥65)   cohort with mean 6.4 y follow up        1589 (725/864)        1--2 times/wk, 3 or more times/wk vs. less often than weekly                                                          NINCDS-ADRDA for AD                                                                                                     1--2 times per week HR = 1.49 (0.43--5.16); 3 times or more per week 1.70 (0.67--4.33); Less Often Than Weekly 1.00                                                                                                                                                Years of education, gender, regular physical activity, body mass index, baseline CASI score, olfaction diagnostic group, total energy intake, intake of saturated, monounsaturated, and polyunsaturated fatty acids, ApoE genotype, smoking status, alcohol drinking, supplementation of vitamin C, vitamin E, and multivitamin, and tea drinking, and fruit and vegetable juice drinking, dietary intake of vitamin C, vitamin E, and *Beta*-carotene
  Ding 2012 \[[@pone.0165861.ref020]\]                Chinese (\>60)                                        case-control                            3,141 (1,438/1,703)   ≥3 d/wk vs. not drinking                                                                                              C-MMSE and AVLT for CoI                                                                                                 OR = 0.36 (0.17, 0.75) for AD                                                                                                                                                                                                                                      Sex, age, education, marriage, BMI, ApoE 4, family economic status in childhood, experience significant adverse events, smoking, drinking, doing physical job before retire, have physical training habit, have many sisters and brothers, family history of dementia, history of hypertension, diabetes, coronary heart disease, stroke and hyperlipidemia
  OR = 0.74 (0.56, 0.98) for MCI                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  Eskelinen 2009 \[[@pone.0165861.ref038]\]           Finland (50.4 ±6.0 for women and 71.3±4.0 for men)    cross-sectional                         1,409 (543/875)       ≥1 cup/day vs. not drinking                                                                                           MMSE≤24 and DSM-IV for dementia; MMSE≤24 and NINCDS-ADRDA for AD                                                        OR = 1.04 (0.59, 1.84) for dementia, OR = 0.91 (0.48, 1.71) for AD, and OR = 1.27 (0.84, 1.91) for all the demented).                                                                                                                                              Midlife smoking, SBP, serum total cholesterol, BMI, and physical activity.
  Forster 1995 \[[@pone.0165861.ref011]\]             English (≥65 with mean onset age of 55.9±3.9)         case-control                            218                   \>4 cups/d of tea vs. not drinking                                                                                    NINCDS-ADRDA criteria for AD, DSM-III-R criteria for dementia, MMSE for CoI                                             OR = 1.40 (0.81, 1.63)                                                                                                                                                                                                                                             NA
  Guo 2011 \[[@pone.0165861.ref021]\]                 Chinese (≥65)                                         hospital based case-control             214 (105/109)         tea drinking vs. not drinking                                                                                         AD diagnosis: C-MMSE, MoCA \<24; CDR \>1; HIS≤4; FAQ≥5; and NINCDS-ADRDA                                                controls: 93 tea drinkers (17 \<4times/wk and 76 \>4times/wk) and 58 never drink; AD cases: 33 tea drinkers (15 \<4 times/wk and 18 \>4 times/wk) and 30 never drink                                                                                               NA
  Huang 2009 \[[@pone.0165861.ref048]\]               Chinese (90--108)                                     cross-sectional                         681 (223 /458)        drinking former vs. not drinking                                                                                      MMSE\<24 for CoI                                                                                                        men: OR = 0.917 (0.344, 2.449); women: OR = 0.862 (0.265, 0.907)                                                                                                                                                                                                   Age, sex, sleep habits, educational levels, religion habits, and temperament.
  Kuriyama 2006 \[[@pone.0165861.ref009]\]            Japanese (≥70)                                        cross-sectional                         1,003                 3 cups/wk vs. 4--6 cups/wk or 1 cup/d, and 2 cups/d (100 mL/cup)                                                      MMSE ≤26 for CoI                                                                                                        For green tea consumption, the OR = 1.00 (reference) for\<3 cups/wk, 0.62 (0.33,1.19) for 4--6 cups/wk or 1 cup/d, and 0.46 (0.30, 0.72) for 2 cups/d. Corresponding ORs were 1.00 (reference), 0.60 (0.35, 1.02), and 0.87 (0.55, 1.38) for black or oolong tea   NA
  Lian 2013 \[[@pone.0165861.ref022]\]                Chinese (≥60)                                         case-control                            240 (104/136)         drinking everyday vs. not drinking                                                                                    C-MMSE and DSM-IV for MCI                                                                                               OR = 0.73 (0.47, 1.13)                                                                                                                                                                                                                                             NA
  Lindsay 2002 \[[@pone.0165861.ref012]\]             Canadian (≥65)                                        cohort with 5y follow up                4,088 (1,718/2,370)   tea drinking vs. not drinking                                                                                         mMMSE \<78/100 and clinical evaluation for AD                                                                           OR = 1.12(0.78, 1.61)                                                                                                                                                                                                                                              Age, sex, and education.
  Luo 2015 \[[@pone.0165861.ref023]\]                 Chinese (≥65)                                         case-control                            1,981 (817/1,168)     tea drinking vs. not drinking                                                                                         Petersen's criteria for MCI                                                                                             102 MCI patients in 932 tea drinkers and 197 patients in 1049 non-drinkers                                                                                                                                                                                         NA
  Ng 2008 \[[@pone.0165861.ref024]\]                  Chinese living in Singapore (≥55)                     cross-sectional                         2,194                 drinking tea with low, medium and high levels vs. not drinking                                                        MMSE ≤23 as CoI, a drop in MMSE score of ≥1 point as cognitive decline                                                  For CoI: Low intake 0.56 (0.40,0.78), Medium 0.45 (0.27, 0.72), high 0.37 (0.14, 0.98); for cognitive decline: Low intake 0.74 (0.54, 1.00), Medium 0.78 (0.55, 1.11), High 0.57 (0.32, 1.03)                                                                      Age, sex, education, smoking, alcohol consumption, BMI (continuous), hypertension, diabetes, heart disease, stroke, depression, APOE 4, physical activities, social and productive activities, vegetable and fruit consumption, fish consumption, and coffee consumption.
  Noguchi-Shinohara 2014 \[[@pone.0165861.ref025]\]   Japanese (≥60)                                        cohort with mean follow up of 4.9y      490                   For green tea, drinking moderate and every day vs. not drinking; for black tea, drinking 1--7 d/wk vs. not drinking   MMSE \<24 for CoI                                                                                                       For dementia, the OR were 0.90 (0.34, 2.35) for 1--6 days/week and 0.26 (0.06, 1.06) for every day. For cognitive decline (MCI or dementia), the OR were 0.47 (0.25, 0.86) and 0.32 (0.16, 0.64) for 1--6 days/week and every day, respectively.                   Age and sex, history of hypertension, diabetes mellitus, hyperlipidemia, education, ApoE E4 carrier status, alcohol drinking, smoking, physical activities and/or hobbies, and coffee and black tea consumption.
  Nurk 2009 \[[@pone.0165861.ref006]\]                Norwegian (70--74)                                    cross-sectional                         2,031 (914/1,117)     tea drinking vs. not drinking                                                                                         mMMSE ≤10 for CoI                                                                                                       OR = 0.33 (0.16, 0.69)                                                                                                                                                                                                                                             All values are adjusted for sex, education, vitamin supplement use (multivitamins, folate, and vitamins B, C, D, or E), smoking status,history of CVD, diabetes, and total energy intake.
  Pan 2012 \[[@pone.0165861.ref026]\]                 Chinese (\>60)                                        cross-sectional                         897 (434/463)         drinking occasionally, drinking often vs. not drinking                                                                MoCA and MMSE for MCI                                                                                                   OR = 0.751 (0.593, 0.951)                                                                                                                                                                                                                                          Age, education, sleep, social activity and study
  Shen 2015 \[[@pone.0165861.ref031]\]                Chinese (≥60)                                         cross-sectional                         9,375 (4,548/4,827)   \<2 cups/d, 2-4cups/d and ≥4 cups/d vs. not drinking (250 mL/cup)                                                     C-MMSE for CoI                                                                                                          compared with non-consumption participants, those who consumed \< 2 cups/d, 2--4 cups/d, and ≥4 cups/d were observed ORs of 0.77 (0.56, 1.07), 0.62 (0.47, 0.81), and 0.49 (0.36, 0.66), respectively.                                                             Age, sex, race, education, marriage, tea concentration, tea categories, physical examinations (BMI, WHR, SBP, DBP), family status (family income, have children or not) and disease situation (history of present illness and family history of hypertension, diabetes, CHD, AD, PD), behavioral risk factors (cigarette smoking, alcohol consumption, and physical activities), dietary intake (vegetables, fruits, red meat, fish, beans, milk), nutrition supplement, depression and ADL
  Song 2007 \[[@pone.0165861.ref027]\]                Chinese (\>60)                                        cross-sectional                         3,047 (2,618/429)     tea drinking vs. not drinking                                                                                         CCMD2-R, DSM-IV and ICD-10 for dementia; MoCA and MMSE for MCI                                                          371 MCI patients in 1788 tea drinkers and 350 patients in 1259 non-drinkers                                                                                                                                                                                        NA
  Sun 2012 \[[@pone.0165861.ref033]\]                 Chinese (≥60)                                         case-control                            168 (48/120)                                                                                                                                C-MMSE for CoI, clinical test, DSM- IV, ADL and CSDD for dementia                                                       OR 0.778 (0.607, 0.996)                                                                                                                                                                                                                                            Hypertension, smoking, drinking, physical activity, live alone, insomnia, bland diet, high cholesterol, high blood glucose, uric acid, thin and fat
  Wang 2012 \[[@pone.0165861.ref028]\]                Chinese (\>60)                                        case-control                            174                   drinking everyday, 1--4 d/wk, occasionally vs. not drinking                                                           DSM-IV, NINCDS-ADRDA and clinical test for VD                                                                           drinking occasionally OR = 0.52 (0.15, 1.82), 1-4d/wk OR = 0.41 (0.11, 1.57), everyday OR = 0.35 (0.18, 0.68)                                                                                                                                                      Economic income, hypertension, education and location
  Wang 2014 \[[@pone.0165861.ref036]\]                Chinese (≥65)                                         cohort with 2 year follow up            223 (70/153)          drink sometimes, often vs. never drinking                                                                             A drop of ≥ 2 MMSE points as cognitive decline                                                                          146 non cognitive decline: 30 never drink green tea, 19 drink sometimes and 97 drink often; 74 cognitive decline: 26 never drink green tea, 8 drink sometimes and 40 drink often                                                                                   Age, non-Chinese speaking background and education, and a formal diagnosis of dementia
  Wu 2011 \[[@pone.0165861.ref037]\]                  Chinese (≥65)                                         cross sectional                         2,119 (1017/1102)     \< 1 time/wk, \> 1 time/wk vs. not drinking                                                                           MMSE\<24 for CoI                                                                                                        less than once per week 1.14 (0.82--1.59) more than once per week 0.99 (0.75--1.3)                                                                                                                                                                                 Age, gender, education level, marital status, social support, hyperlipidemia, stroke, physical function, depressive symptoms, self-rated health, cigarette smoking, leisure-time, physical activity, fruits and vegetables consumption, coffee intake, multivitamin intake, BMI
  Xu 2012 \[[@pone.0165861.ref029]\]                  Chinese (≥50)                                         cross-sectional                         3,485 (1,126/2,359)   green tea drinking vs. not drinking                                                                                   C-MMSE, CDT and Mini-Cog for CoI                                                                                        OR = 0.56 (0.40, 0.79)                                                                                                                                                                                                                                             NA
  Yao 2010 \[[@pone.0165861.ref039]\]                 Chinese (≥60)                                         cross-sectional                         2,809 (1,010/1,799)   tea drinking daily vs. not drinking                                                                                   C-MMSE                                                                                                                  64 CoI patients in 1244 tea drinkers; 131 CoI patients in 1503 non-tea drinkers                                                                                                                                                                                    NA
  Yin 2012 \[[@pone.0165861.ref030]\]                 Chinese (≥65)                                         cross-sectional                         1,011 (410/601)       tea drinking vs. not drinking                                                                                         Petersen's criteria for MCI diagnosis                                                                                   44 MCI patients in 687 tea drinkers and 23 patients in 324 non-drinkers                                                                                                                                                                                            NA

Notes: MMSE: Mini-Mental State Examination

C-MMSE (Chinese revised MMSE): ≤24 for people with more than 6 years education, ≤20 for people with 1--6 years of education, ≤17 for illiteracy mild cognitive impairment

HDS: Hasegawa Dementia Scale, HIS: Hachinski ischemia score, MoCA: montreal cognitive assessment scale, ADL: activities of daily living scale

CSDD: the Chinese version of the Cornell scale for depression in dementia, AVLT: Auditory verbal learning test, CMS: Clinical Memory Scale

[Table 2](#pone.0165861.t002){ref-type="table"} showed the quality assessment of the included case-control studies and cohorts. The studies were awarded relatively high quality.

10.1371/journal.pone.0165861.t002

###### The quality assessment of the included studies.

![](pone.0165861.t002){#pone.0165861.t002g}

  Study                    Selection   Comparability   Exposure/Outcome   Total
  ------------------------ ----------- --------------- ------------------ -------
  Case-control studies                                                    
  Broe 1990                ☆☆☆☆        ☆               ☆☆☆                8
  Chen 2012                ☆☆☆☆        ☆               ☆                  6
  Ding                     ☆☆☆         ☆               ☆☆                 6
  Forster 1995             ☆☆☆☆        ☆               ☆                  6
  Guo 2011                 ☆☆☆☆        ☆☆              ☆☆                 8
  Lian 2013                ☆☆☆☆        ☆☆              ☆☆                 8
  Lindsay 2002             ☆☆☆         ☆☆              ☆☆                 7
  Luo 2015                 ☆☆☆☆        ☆               ☆☆                 7
  Wang 2012                ☆☆☆☆        ☆☆              ☆☆                 8
  Sun 2012                 ☆☆☆☆        ☆☆              ☆                  7
  Cohort studies                                                          
  Dai 2006                 ☆☆☆         ☆☆              ☆☆                 7
  Ng 2008                  ☆☆☆         ☆☆              ☆                  6
  Noguchi-Shinohara 2014   ☆☆☆☆        ☆☆              ☆☆                 8
  Wang 2014                ☆☆☆☆        ☆               ☆☆                 7

Association of tea intake and the risk of cognitive disorders {#sec014}
-------------------------------------------------------------

As shown in [Fig 2](#pone.0165861.g002){ref-type="fig"}, a significant heterogeneity (*I*^*2*^ = 78.8%) was found. Thus, a random effects model was used in this meta-analysis. The forest plot showed that tea drinking was inversely associated with the risk of cognitive disorders (OR = 0.65, 95%CI = 0.58--0.73).

![Overall pooled analysis of association between tea intake and the cognitive disorders.](pone.0165861.g002){#pone.0165861.g002}

Subgroup analyses {#sec015}
-----------------

Based on the study design, we classified all studies into three subgroups: case-control, cohort and cross-sectional ([Fig 3](#pone.0165861.g003){ref-type="fig"}). Each of the three subgroups showed an inverse correlation between tea drinking and cognitive disorder. In population subgroups ([Fig 4](#pone.0165861.g004){ref-type="fig"}), tea drinking could significantly reduce the risk of cognitive disorders in Chinese (OR = 0.61, 95%CI = 0.54--0.69). However, no significant associations were found in European (OR = 0.98, 95%CI = 0.21--1.75) and Japanese populations (OR = 0.76, 95%CI = 0.39--1.13). In subgroups by drinking frequency ([Fig 5](#pone.0165861.g005){ref-type="fig"}), all of the tea drinkers showed significant lower risk of cognitive disorders compared to those not drinking or rare drinking. In subgroup analysis based on type of cognitive disorders ([Fig 6](#pone.0165861.g006){ref-type="fig"}), drinking tea could significantly lower the risk of CoI (OR = 0.52, 95%CI = 0.43--0.62), MCI (OR = 0.64, 95%CI = 0.52--0.76), cognitive decline (OR = 0.74, 95%CI = 0.58--0.90) and unclassified cognitive disorder (OR = 0.76, 95%CI = 0.60--0.91). However, no significant association was found between tea intake and dementia or AD (OR = 0.88, 95%CI = 0.65--1.12).

![Subgroup analysis of association between tea intake and the cognitive disorders based on study design.](pone.0165861.g003){#pone.0165861.g003}

![Subgroup analysis of association between tea intake and the cognitive disorders based on population.](pone.0165861.g004){#pone.0165861.g004}

![Subgroup analysis of association between tea intake and the cognitive disorders based on tea drinking frequency.\
Ungrouped means studies without information on drinking frequency.](pone.0165861.g005){#pone.0165861.g005}

![Subgroup analysis of association between tea intake and the cognitive disorders based on type of cognitive disorders.](pone.0165861.g006){#pone.0165861.g006}

Publication bias {#sec016}
----------------

Publication bias was assessed according to the overall pooled analysis. Begg's test (*P* = 0.691), Egger's test (*P* = 0.707) and the symmetrical funnel plot ([Fig 7](#pone.0165861.g007){ref-type="fig"}) indicated no publication bias in this meta-analysis.

![Funnel plot for assessment of publication bias.](pone.0165861.g007){#pone.0165861.g007}

Discussion {#sec017}
==========

In the current meta-analysis, we found that tea intake could significantly reduce the risk of cognitive disorders in elderly. Subgroup analyses showed similar results in subgroups. Our results were the opposite of a recent meta-analysis which found no association between caffeine from coffee or tea and cognitive disorders \[[@pone.0165861.ref013]\]. Caffeine is an important component in tea and coffee. Many experimental studies also showed the benefits of caffeine on cognitive function. For an instance, in aged mice with AD, caffeine could reverse CoI and decrease brain amyloid-β levels \[[@pone.0165861.ref040]\]. But unlike coffee, there are so many other beneficial elements aside from caffeine in tea including the polyphenols which have antioxidant effect \[[@pone.0165861.ref041],[@pone.0165861.ref042]\]. Accumulating evidence showed the neuroprotective activity of the main catechin (-)-epigallocatechin-3-gallate (EGCG) from tea \[[@pone.0165861.ref043]\]. Chronic green tea EGCG could improve learning and memory deficits in diabetic rats via retardation of oxidative stress and modulation of nitric oxide \[[@pone.0165861.ref044]\]. In Alzheimer transgenic mice, EGCG showed the protective effect through modulating cleavage of amyloid precursor protein and reducing cerebral amyloidosis \[[@pone.0165861.ref045]\]. As above, the cognition protective effect of tea may be owing to the catechin and caffeine components.

Tea has several subtypes based on the processing technology, such as green, black and oolong tea. These subtypes of tea have different content of catechins and caffeine. Among the tea types commonly consumed, the highest catechins and caffeine were found in green tea and black tea, respectively \[[@pone.0165861.ref046]\]. In the present meta-analysis, an included study \[[@pone.0165861.ref024]\] showed significant decrease of the CoI incidence in black and oolong tea drinkers (OR = 0.55, 95%CI = 0.40--0.76) and green tea drinkers (OR = 0.42, 95%CI = 0.25--0.69). Because the black and oolong tea were combined in one category, we were not sure if black tea has a different effect from green tea on preventing the progression of CoI. In another study \[[@pone.0165861.ref029]\], green tea drinking was also associated with reduced risk of CoI (OR = 0.56, 95%CI = 0.40--0.79). However, whether green tea is more beneficial cannot be certain due to lack of comparison with other types of tea. Therefore, tea types should be considered in future studies.

In subgroup analysis, we found that tea intake could significantly reduce the risk of cognitive disorders in Chinese, but not in Japanese and Europeans. Because only one study each considered Australian \[[@pone.0165861.ref032]\] and Canadian patients \[[@pone.0165861.ref012]\], they were not included in subgroup analysis. Both two studies showed no significant association between tea intake and cognitive disorders ([Fig 2](#pone.0165861.g002){ref-type="fig"}). We think that the major reason is the different outcomes among the included studies. For the Chinese group, the major outcome was CoI or MCI. However, for European, Australian and Canadian groups, the major outcome was AD. This is consistent with the subgroup analysis in terms of outcomes which showed no association between tea intake and AD. A Japanese study \[[@pone.0165861.ref025]\] showed an obvious association between tea intake and MCI, but no obvious association was found in the outcome of AD ([Fig 6](#pone.0165861.g006){ref-type="fig"}). Nonetheless, we cannot draw a conclusion that there has no association between tea drinking and AD, because of lack of included studies, especially lack of non-Chinese studies. As well, the larger sample sizes in CoI studies than AD studies would influence the pooled result ([Table 1](#pone.0165861.t001){ref-type="table"}). In addition to the above reasons, the origin of the studies, the locations/regions of studied populations and the sample size would also affect the results of the pooled analyses. Except for tea drink frequency, the intake duration is also an important factor influencing the overall pooled result. However, only one study \[[@pone.0165861.ref021]\] considered the tea intake duration, and drinking tea more than 10 years did not decrease the risk of AD compared to the people drinking less than 10 years (OR = 0.43, 95%CI = 0.17--1.05). This result should be confirmed by larger sample studies in future. It also reminds the researchers considering the effect of tea intake duration in further experiment design.

Our meta-analysis has strengths, such as no publication bias. Publication bias is an important factor influencing the quality and reliability of meta-analysis. In this meta-analysis, symmetric distribution of the included studies would improve the reliability of the statistical analysis to an extent. Subgroup analyses could evaluate the effect of the study design, population, drinking frequency and different cognitive disorders on the overall pooled result. In addition, our meta-analysis included more Chinese studies than the previous one \[[@pone.0165861.ref013]\]. Tea drinkers may be easier to find in Chinese people.

Nevertheless, this meta-analysis has several limitations. Firstly, there were no double-blind placebo controlled trials regarding this topic. All of the included studies were observational studies. Also, some confounders were not adjusted in the original studies. Therefore, the confounders would cause bias in our pooled results. Secondly, it is difficult to ensure the tea drink frequency and volume of the participants. Some included studies did not classify the tea drinkers by drink frequency and volume. The cognitive protective effects of tea are usually dose dependent. If the tea drink history of the participants was unclear, the pooled analysis would be neutralized. Thirdly, different diagnostic criteria were used in the original studies. Finally, significant heterogeneity was found in our meta-analysis. One of the major causes might be the various cut-off value of MMSE (range from 10 to 26) for CoI diagnosis. Besides, female and older population may have a higher risk of cognitive disorders \[[@pone.0165861.ref047]\]. Thus, some other potential confounders like age, gender and lifestyles may partially contribute to the heterogeneity.

In conclusion, we meta-analyzed 26 observational studies and found that daily tea drinking could decrease the risk of CoI, MCI and cognitive decline in elderly. However, no association was found between tea intake and AD. Further studies are needed to confirm our findings.
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